Literature DB >> 24449201

Newly described clinical features in two siblings with MACS syndrome and a novel mutation in RIN2.

Ayca D Aslanger1, Umut Altunoglu, Emre Aslanger, Bilge N Satkın, Zehra Oya Uyguner, Hülya Kayserili.   

Abstract

The disorder comprising Macrocephaly, Alopecia, Cutis laxa, and Scoliosis has been designated MACS syndrome. It is a rare condition, inherited in an autosomal recessive pattern. Three families from different ethnic origins have so far been reported and were all linked to homozygous mutations in RIN2, a gene encoding the Ras and Rab interactor 2 protein involved in cell trafficking. We describe herein the fourth family with MACS syndrome in two siblings carrying a novel homozygous mutation, c.1878_1879insC in exon 8 of the RIN2 gene, which predicts p.Ile627Hisfs*7. We also report on additional findings not previously described in MACS syndrome, including bronchiectasis and hypergonadotropic hypogonadism. Finally, our overall data support the argument that RIN2 syndrome is a more appropriate name for the disorder.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Ehlers-Danlos-like syndromes; MACS/RIN2 syndrome; RIN2; cutis laxa-like syndromes

Mesh:

Substances:

Year:  2013        PMID: 24449201     DOI: 10.1002/ajmg.a.36277

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  2 in total

Review 1.  A clinical review on megalencephaly: A large brain as a possible sign of cerebral impairment.

Authors:  Piero Pavone; Andrea Domenico Praticò; Renata Rizzo; Giovanni Corsello; Martino Ruggieri; Enrico Parano; Raffaele Falsaperla
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

Review 2.  Clinical and molecular characterization of an 18-month-old infant with autosomal recessive cutis laxa type 1C due to a novel LTBP4 pathogenic variant, and literature review.

Authors:  Marco Ritelli; Francisco Cammarata-Scalisi; Valeria Cinquina; Marina Colombi
Journal:  Mol Genet Genomic Med       Date:  2019-05-21       Impact factor: 2.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.